What Quest Diagnostics's 8-K filings say: 5 filings, latest Oct 22, 2026
Quest Diagnostics filed its latest 8-K with the SEC on Oct 22, 2026. It discusses product launch and software implementation.
Public (DGX)Hospitals and Health Care10,000+ employeesquestdiagnostics.comLinkedIn
Get Quest Diagnostics' live signals in Claude or ChatGPT, or by API
What changed at Quest Diagnostics this week? Use Autobound signals for questdiagnostics.com.- Filed
- Oct 22, 2026
- Filings
- 5
- Signals
- 8
Source: Autobound Signal API · 71 signals tracked for Quest Diagnostics · updated
8-K · latest 6
What Quest Diagnostics's 8-K filings say
- SEC EDGAR
8-K
Filed · 2 signals
Quest Diagnostics Advances Project Nova to Build Phase, Targeting Fall 2027 Epic Deployment
Quest Diagnostics advanced its Project Nova initiative from the design phase to the solutions-build phase and expects to deploy Epic solutions in its first lab in fall 2027.
Epic solutionsEpic
Quest Diagnostics extended AD-Detect menu with Roche Elecsys pTau217 blood test panel
Quest Diagnostics expanded its AD-Detect portfolio to include the FDA-cleared Roche Elecsys pTau217 plasma blood test and launched a new biomarker panel for Alzheimer's disease diagnosis.
- SEC EDGAR
8-K
Filed · 1 signal
EVP Catherine Doherty to lead 'Project Nova' IT modernization before July 2027 retirement.
Catherine Doherty is transitioning to a new EVP role, effective Nov 1, 2026, to spearhead 'Project Nova,' a multi-year initiative to modernize the company's 'Order to Cash' business processes and underlying IT infrastructure.
$1.2M
Target value of equity award for Catherine T. Doherty related to her new responsibilities.
Corewell Health
- SEC EDGAR
8-K
Filed · 2 signals
Quest Diagnostics raises $500M in cash via senior notes due 2036
Quest Diagnostics has secured $500 million in new capital, signaling significant upcoming investments or strategic initiatives.
$500M
aggregate principal amount of senior notes issued
5%
interest rate on senior notes due 2036
The Bank of New York MellonAllen Overy Shearman Sterling US LLP
- SEC EDGAR
8-K
Filed · 2 signals
Quest Diagnostics raises $500M in senior notes for debt repayment and general corporate purposes.
$500M
Public offering of senior notes for general corporate purposes and potential debt repayment
Goldman Sachs & Co. LLCJ.P. Morgan Securities LLCMizuho Securities USA LLC
- SEC EDGAR
8-K
Filed · 1 signal
Quest Diagnostics authorizes $1B stock repurchase and increases dividend by 7.5%
The board's authorization of a new $1 billion share repurchase program and a 7.5% dividend increase signals strong financial health and robust cash flow.
$1B
common stock repurchase authorization
7.5%
increase in quarterly dividend
Showing 6 of 8 filing signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Quest Diagnostics with the Signal API
One POST /v1/companies/enrich call with questdiagnostics.com returns Quest Diagnostics 8-K signals (sec-8k), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"questdiagnostics.com","signal_types":["sec-8k"],"limit":20}'Bulk data
Need this signal for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real 8-K Filings records, as a CSV.
Same industry
8-K at related companies
Questions about Quest Diagnostics 8-K
When did Quest Diagnostics file its latest 8-K?
What did Quest Diagnostics disclose in its latest 8-K?
Where can I read Quest Diagnostics's 8-K filing?
Page updated , the date of the newest row on this page.
Source. Current reports (Form 8-K) filed with the SEC. Every card links to the filing on EDGAR.
Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.
Data as of .